Cargando…
Doxorubicin uptake in ascitic lymphoma model: resistance or curability is governed by tumor cell density and prolonged drug retention
Background/Aims: Chemotherapy resistance of malignancies is a universal phenomenon which unfavorably affects therapeutic results. Genetic adaptations as well as epigenetic factors can play an important role in the development of multidrug resistance. Cytotoxic drug content in plasma of cancer patien...
Autores principales: | Zaleskis, Gintaras, Garberytė, Sima, Pavliukevičienė, Božena, Valinčius, Gintaras, Characiejus, Dainius, Mauricas, Mykolas, Kraśko, Jan Aleksander, Žilionytė, Karolina, Žvirblė, Margarita, Pašukonienė, Vita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545667/ https://www.ncbi.nlm.nih.gov/pubmed/33046971 http://dx.doi.org/10.7150/jca.46066 |
Ejemplares similares
-
Do the benefits of being a smoker hint at the existence of PD-1/PD-L1 sensitizers for patients on single-agent immunotherapy?
por: Zaleskis, Gintaras, et al.
Publicado: (2021) -
Letter to the Editor Re: Yamamoto R, Sugiura T, Ashida R, Ohgi K, Yamada M, Otsuka S, and Uesaka K. Prognostic value of carbohydrate antigen 19‐9 and the surgical margin in extrahepatic cholangiocarcinoma. Ann Gastroenterol Surg. 2022; 6:307–315
por: Zaleskis, Gintaras, et al.
Publicado: (2023) -
A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample
por: Eidukevicius, Rimantas, et al.
Publicado: (2005) -
Correction: a method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample
por: Eidukevicius, Rimantas, et al.
Publicado: (2006) -
Letter to the Editor: No immunophenotyping in peripheral blood of prostate cancer patients treated with neoadjuvant Rituximab?
por: Bosas, Paulius, et al.
Publicado: (2020)